The current contract is a study focused on Sequelae and Immunopathology of Ebola Virus Infections.  This modification is necessary to respond to the ongoing 2019-nCoV virus (nCoV) outbreak and leverages the technology and methodology for examining Ebola sequelae and Zika immunopathology to extend analysis and gather critical information about the nature of nCoV virus infection. This work aims to characterize the effects of nCoV virus infection using samples from non-human primate (NHP) animal models and human tissues (pending availability) to empower future regulatory decision making. Stanford shall apply a set of technologies for high parameter antibody-based profiling of blood and tissues (CyTOF, CODEX) along with viral nucleic acid detection in situ (viralMIBI).